Showing 1,701 - 1,720 results of 27,215 for search '(( 50 ((ng decrease) OR (a decrease)) ) OR ( 5 ((nn decrease) OR (teer decrease)) ))', query time: 1.26s Refine Results
  1. 1701
  2. 1702
  3. 1703
  4. 1704

    Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

    Published 2009
    “…[Me<sub>2</sub>NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me<sub>2</sub>NN]Cu}<sub>2</sub>(μ-η<sup>2</sup>:η<sup>1</sup>-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η<sup>2</sup> and η<sup>1</sup> bonding of the ArNO moiety with separate [Me<sub>2</sub>NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”
  5. 1705

    Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

    Published 2009
    “…[Me<sub>2</sub>NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me<sub>2</sub>NN]Cu}<sub>2</sub>(μ-η<sup>2</sup>:η<sup>1</sup>-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η<sup>2</sup> and η<sup>1</sup> bonding of the ArNO moiety with separate [Me<sub>2</sub>NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”
  6. 1706

    Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

    Published 2009
    “…[Me<sub>2</sub>NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me<sub>2</sub>NN]Cu}<sub>2</sub>(μ-η<sup>2</sup>:η<sup>1</sup>-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η<sup>2</sup> and η<sup>1</sup> bonding of the ArNO moiety with separate [Me<sub>2</sub>NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”
  7. 1707

    Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

    Published 2009
    “…[Me<sub>2</sub>NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me<sub>2</sub>NN]Cu}<sub>2</sub>(μ-η<sup>2</sup>:η<sup>1</sup>-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η<sup>2</sup> and η<sup>1</sup> bonding of the ArNO moiety with separate [Me<sub>2</sub>NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”
  8. 1708

    Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

    Published 2009
    “…[Me<sub>2</sub>NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me<sub>2</sub>NN]Cu}<sub>2</sub>(μ-η<sup>2</sup>:η<sup>1</sup>-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η<sup>2</sup> and η<sup>1</sup> bonding of the ArNO moiety with separate [Me<sub>2</sub>NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”
  9. 1709

    Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

    Published 2009
    “…[Me<sub>2</sub>NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me<sub>2</sub>NN]Cu}<sub>2</sub>(μ-η<sup>2</sup>:η<sup>1</sup>-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η<sup>2</sup> and η<sup>1</sup> bonding of the ArNO moiety with separate [Me<sub>2</sub>NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”
  10. 1710
  11. 1711

    Effect of incubation time on IC<sub>50</sub>s for zanamivir, oseltamivir and peramivir. by Susan Barrett (209202)

    Published 2011
    “…(A) Final higher IC<sub>50</sub> values for binding of zanamivir without preincubation compared to preincubation and the decreases in IC<sub>50</sub>s without preincubation over the 60 min correlate with slow binding. …”
  12. 1712

    Table_4_Clinical Features of 50 Patients With Primary Adrenal Lymphoma.DOCX by Yan Wang (15435)

    Published 2020
    “…<p>Background and Objective: Primary adrenal lymphoma is a rare, progressive, easily misdiagnosed adrenal tumor with a poor prognosis. …”
  13. 1713

    Table_1_Clinical Features of 50 Patients With Primary Adrenal Lymphoma.DOCX by Yan Wang (15435)

    Published 2020
    “…<p>Background and Objective: Primary adrenal lymphoma is a rare, progressive, easily misdiagnosed adrenal tumor with a poor prognosis. …”
  14. 1714

    Table_2_Clinical Features of 50 Patients With Primary Adrenal Lymphoma.DOCX by Yan Wang (15435)

    Published 2020
    “…<p>Background and Objective: Primary adrenal lymphoma is a rare, progressive, easily misdiagnosed adrenal tumor with a poor prognosis. …”
  15. 1715
  16. 1716
  17. 1717
  18. 1718
  19. 1719
  20. 1720

    The Impact of Prophylactic Dexamethasone on Nausea and Vomiting after Thyroidectomy: A Systematic Review and Meta-Analysis by Zhenhong Zou (645858)

    Published 2014
    “…The meta-analysis demonstrated a significant decrease in the incidence of PONV (RR 0.52, 95% CI 0.43 to 0.63, <i>P</i><0.00001), the need for rescue anti-emetics (RR 0.42, 95% CI 0.30 to 0.57, <i>P</i><0.00001), post-operative pain scores (WMD –1.17, 95% CI –1.91 to –0.44, <i>P</i> = 0.002), and the need for rescue analgesics (RR 0.65, 95% CI 0.50–0.83, <i>P</i> = 0.0008) in patients receiving dexamethasone compared to placebo, with or without concomitant antiemetics. …”